TD Cowen Maintains Buy on BeOne Medicines, Raises Price Target to $454

Benzinga · 3d ago
TD Cowen analyst Yaron Werber maintains BeOne Medicines (NASDAQ:ONC) with a Buy and raises the price target from $424 to $454.